LT - 2-6-(3-Amino-piperidin-1-il)-3-metil-2,4-diokso-3,4-dihidro-2H-pirimidin-1-ilmetil]-4-fluor-benzonitrilas, skirtas diabeto, vėžio, autoimuninių sutrikimų ir ŽIV infekcijos gydymui
EN - USE OF 2-6-(3-AMINO-PIPERIDIN-1-YL)-3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YLMETHYL-4-FLUORO-BENZONITRILE FOR TREATING DIABETES, CANCER, AUTOIMMUNE DISORDERS AND HIV INFECTION
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/513 |
(2006.01) |
|
|
A61P 3/10 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
|
|
A61P 31/18 |
(2006.01) |
|
|
A61P 5/50 |
(2006.01) |
European patent
| (11) |
Number of the document |
2073810 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
07842260.7 |
|
Date of filing the European patent application |
2007-09-11 |
| (97) |
Date of publication of the European application |
2009-07-01 |
| (45) |
Date of publication and mention of the grant of the patent |
2011-08-31
|
| (46) |
Date of publication of the claims translation |
2012-01-25
|
PCT application
| (86) |
Number |
PCT/US2007/078177 |
|
Date |
2007-09-11 |
PCT application publication
| (87) |
Number |
WO 2008/033851 |
|
Date |
2008-03-20 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
PCT/US2006/0359 |
2006-09-13
|
WO |
|
894628 P |
2007-03-13
|
US |
Inventors
| (72) |
CHRISTOPHER, Ronald J., US
OGAWA, Atsushi, JP
COVINGTON, Paul, US
|
Grantee
| (73) |
Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome Chuo-ku, Osaka- shi, Osaka 541-0045,
JP
|
Attorney or representative
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
Title
| (54) |
2-6-(3-Amino-piperidin-1-il)-3-metil-2,4-diokso-3,4-dihidro-2H-pirimidin-1-ilmetil]-4-fluor-benzonitrilas, skirtas diabeto, vėžio, autoimuninių sutrikimų ir ŽIV infekcijos gydymui |
| |
USE OF 2-6-(3-AMINO-PIPERIDIN-1-YL)-3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YLMETHYL-4-FLUORO-BENZONITRILE FOR TREATING DIABETES, CANCER, AUTOIMMUNE DISORDERS AND HIV INFECTION |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-08-20 |
19 |
347.00
EUR
|
Next renewal fee
|
2026-09-11 |
